Aberdeen Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$155M Sell
382,241
-33,316
-8% -$13.5M 0.26% 77
2025
Q1
$205M Buy
415,557
+155,576
+60% +$76.6M 0.4% 45
2024
Q4
$135M Sell
259,981
-9,482
-4% -$4.91M 0.25% 81
2024
Q3
$165M Buy
269,463
+4,122
+2% +$2.52M 0.3% 68
2024
Q2
$147M Sell
265,341
-23,290
-8% -$12.9M 0.28% 73
2024
Q1
$168M Sell
288,631
-8,141
-3% -$4.73M 0.33% 64
2023
Q4
$158M Buy
296,772
+190,628
+180% +$101M 0.34% 59
2023
Q3
$53.7M Sell
106,144
-8,793
-8% -$4.45M 0.14% 149
2023
Q2
$60M Sell
114,937
-7,797
-6% -$4.07M 0.14% 150
2023
Q1
$70.7M Sell
122,734
-1,704
-1% -$982K 0.18% 121
2022
Q4
$68.5M Sell
124,438
-27,340
-18% -$15.1M 0.19% 120
2022
Q3
$77M Buy
151,778
+31,217
+26% +$15.8M 0.23% 95
2022
Q2
$65.1M Buy
120,561
+2,951
+3% +$1.59M 0.2% 103
2022
Q1
$70.5M Sell
117,610
-20,148
-15% -$12.1M 0.18% 123
2021
Q4
$91.9M Sell
137,758
-10,483
-7% -$6.99M 0.2% 115
2021
Q3
$86M Sell
148,241
-1,287
-0.9% -$746K 0.19% 117
2021
Q2
$75.4M Sell
149,528
-7,073
-5% -$3.57M 0.17% 127
2021
Q1
$71.5M Sell
156,601
-11,487
-7% -$5.25M 0.16% 130
2020
Q4
$78.3M Buy
168,088
+19,794
+13% +$9.22M 0.19% 117
2020
Q3
$65.5M Sell
148,294
-10,449
-7% -$4.61M 0.17% 120
2020
Q2
$57.5M Sell
158,743
-9,207
-5% -$3.34M 0.16% 125
2020
Q1
$47.6M Sell
167,950
-1,878
-1% -$533K 0.15% 127
2019
Q4
$55.2M Sell
169,828
-4,604
-3% -$1.5M 0.13% 138
2019
Q3
$50.8M Sell
174,432
-25,876
-13% -$7.54M 0.13% 145
2019
Q2
$58.8M Sell
200,308
-1,248
-0.6% -$367K 0.13% 148
2019
Q1
$55.2M Buy
201,556
+39,285
+24% +$10.8M 0.12% 153
2018
Q4
$35.9M Sell
162,271
-53,254
-25% -$11.8M 0.09% 216
2018
Q3
$52.6M Sell
215,525
-11,114
-5% -$2.71M 0.1% 195
2018
Q2
$47M Buy
226,639
+57,185
+34% +$11.8M 0.09% 214
2018
Q1
$35M Sell
169,454
-5,645
-3% -$1.17M 0.07% 262
2017
Q4
$33.3M Buy
175,099
+1,646
+0.9% +$313K 0.06% 271
2017
Q3
$32.8M Buy
+173,453
New +$32.8M 0.06% 267